Company Filing History:
1 out of 29 
1 out of 114 
1 out of 832,966 Years Active: 1994-2019
Title: Innovations and Contributions of Inventor Thomas Harrer
Introduction
Thomas Harrer is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of medical technology, particularly in the development of treatments for influenza and cold allergies. With a total of 3 patents, Harrer's work reflects his dedication to advancing healthcare solutions.
Latest Patents
Harrer's latest patents include groundbreaking inventions aimed at improving the detection, prevention, and treatment of influenza. One of his notable patents is the "Influenza-specific T-cell receptor and its uses in the detection, prevention and/or treatment of influenza." This invention focuses on specific T-cell receptor chains that bind to the influenza matrix peptide GILGFVFTL, presented by Human Leukocyte antigen A2 molecules. The patent also covers soluble TCR constructs and their potential use as medicaments in combating influenza.
Another significant patent is "Peptides against autoantibodies causing intolerance to cold and use thereof." This invention involves nucleic acid molecules encoding peptides that target autoantibodies associated with cold allergies. The patent outlines the use of these peptides and nucleic acids in treating circulatory disorders linked to cold exposure, particularly for individuals suffering from cold intolerance.
Career Highlights
Throughout his career, Thomas Harrer has worked with prominent organizations, including Asta Pharma and Friedrich-Alexander-Universität Erlangen-Nürnberg. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical research and innovation.
Collaborations
Harrer has collaborated with notable colleagues such as Joachim Kalden and Bernhard W. Fleckenstein. These partnerships have played a crucial role in the development of his patents and the advancement of medical technologies.
Conclusion
Thomas Harrer's innovative work in the field of medical technology has led to significant advancements in the treatment of influenza and cold allergies. His patents reflect a commitment to improving healthcare solutions and demonstrate the impact of his contributions to the scientific community.